Home > Insider Trading > Filing (0001535610-19-000053)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1371217	Reshape Lifesciences Inc.	RSLS	Electromedical & Electrotherapeutic Apparatus (3845)	481293684

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1535610	Sabby Management, Llc	10 Mountainview Road Suite 205 Upper Saddle River NJ 07458		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-15	167,760	$0.24	1,043,408	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2019-01-16	21,961	$0.27	1,065,369	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2019-01-16	4,700	$0.26	1,070,069	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Footnotes

This Form 4 is being filed by Sabby Volatility Warrant Master Fund, Ltd. ("SVWMF"), Sabby Management, LLC ("Advisor") and Hal Mintz. Advisor is the investment manager of SVWMF. Mr. Mintz is manager of Advisor.
The amounts reported herein reflect the entire amount of Issuer's common shares held by SVWMF as of each transaction date. Each of Advisor and Mr. Mintz disclaims for purposes of Section 16 of the Securities Exchange Act of 1934 ("Section 16"), beneficial ownership of such securities, except to the extent of its/his pecuniary interest therein, and this report shall not be deemed as an admission that either Advisor or Mr. Mintz is the beneficial owner of such securities for purposes of Section 16 or otherwise.